BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 27447175)

  • 1. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.
    Reichrath J; Zouboulis CC; Vogt T; Holick MF
    Rev Endocr Metab Disord; 2016 Sep; 17(3):405-417. PubMed ID: 27447175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenge and perspective: the relevance of ultraviolet (UV) radiation and the vitamin D endocrine system (VDES) for psoriasis and other inflammatory skin diseases.
    Reichrath J; Saternus R; Vogt T
    Photochem Photobiol Sci; 2017 Mar; 16(3):433-444. PubMed ID: 28054069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine actions of vitamin D in skin: Relevance for photocarcinogenesis of non-melanoma skin cancer, and beyond.
    Reichrath J; Saternus R; Vogt T
    Mol Cell Endocrinol; 2017 Sep; 453():96-102. PubMed ID: 28526240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
    Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
    Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamins as hormones.
    Reichrath J; Lehmann B; Carlberg C; Varani J; Zouboulis CC
    Horm Metab Res; 2007 Feb; 39(2):71-84. PubMed ID: 17326003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the vitamin D endocrine system in human sebocytes in vitro.
    Krämer C; Seltmann H; Seifert M; Tilgen W; Zouboulis CC; Reichrath J
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):9-16. PubMed ID: 19027855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocrine vitamin D system in the gut.
    Barbáchano A; Fernández-Barral A; Ferrer-Mayorga G; Costales-Carrera A; Larriba MJ; Muñoz A
    Mol Cell Endocrinol; 2017 Sep; 453():79-87. PubMed ID: 27913273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D endocrine system and psoriasis vulgaris--review of the literature.
    Rucević I; Barisić-Drusko V; Glavas-Obrovac L; Stefanić M
    Acta Dermatovenerol Croat; 2009; 17(3):187-92. PubMed ID: 19818218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro.
    Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3659-67. PubMed ID: 19667162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunological functions of the vitamin D endocrine system.
    Hayes CE; Nashold FE; Spach KM; Pedersen LB
    Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):277-300. PubMed ID: 12887108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
    Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 1,25-dihydroxyvitamin D3-independent actions of the vitamin D receptor in skin.
    Dowd DR; MacDonald PN
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):317-21. PubMed ID: 20362670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
    Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
    Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor modulators for inflammation and cancer.
    Yee YK; Chintalacharuvu SR; Lu J; Nagpal S
    Mini Rev Med Chem; 2005 Aug; 5(8):761-78. PubMed ID: 16101412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Vitamin D Receptor as Tumor Suppressor in Skin.
    Bikle DD
    Adv Exp Med Biol; 2020; 1268():285-306. PubMed ID: 32918224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.